Immunovant shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Immunovant
Tip: Access up to 7 years of quarterly data
All positions including Immunovant held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunovant by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $8.4M | 340k | 24.84 |
| 2025-12-31 | $23M | 893k | 25.42 |
| 2025-09-30 | $3.3M | 205k | 16.12 |
| 2025-06-30 | $1.0M | 61k | 16.95 |
| 2025-03-31 | $13M | 745k | 17.09 |
| 2024-12-31 | $23M | 916k | 24.77 |
| 2024-09-30 | $35M | 1.2M | 28.51 |
| 2024-06-30 | $36M | 1.4M | 26.41 |
| 2024-03-31 | $60M | 1.9M | 32.31 |
| 2023-12-31 | $68M | 1.6M | 42.13 |
| 2023-09-30 | $28M | 730k | 38.39 |
| 2023-06-30 | $371k | 20k | 19.00 |
| 2023-03-31 | $6.9M | 443k | 15.51 |
| 2022-12-31 | $4.9M | 276k | 17.75 |
| 2021-09-30 | $197k | 23k | 8.69 |
| 2021-06-30 | $186k | 18k | 10.57 |
| 2021-03-31 | $277k | 17k | 16.05 |
| 2020-12-31 | $13M | 290k | 46.19 |
| 2020-09-30 | $7.2M | 206k | 35.19 |